Information Journal Paper
APA:
Copy. (2017). Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsingremitting multiple sclerosis. JOURNAL OF NEUROCHEMISTY, 141(2), 296-304. SID. https://sid.ir/paper/783880/en
Vancouver:
Copy. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsingremitting multiple sclerosis. JOURNAL OF NEUROCHEMISTY[Internet]. 2017;141(2):296-304. Available from: https://sid.ir/paper/783880/en
IEEE:
Copy, “Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsingremitting multiple sclerosis,” JOURNAL OF NEUROCHEMISTY, vol. 141, no. 2, pp. 296–304, 2017, [Online]. Available: https://sid.ir/paper/783880/en